Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

68.40p
   
  • Change Today:
    -0.30p
  • 52 Week High: 69.00
  • 52 Week Low: 45.13
  • Currency: UK Pounds
  • Shares Issued: 474.99m
  • Volume: 897,863
  • Market Cap: 324.89m
  • RiskGrade: 122

Alliance Pharma Overview

Alliance Pharma is in the pharma and biotech sector and is currently trading at 68.40p per share. In the last year Alliance Pharma's share price has ranged from 45.13p to 69.00p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 1.8% 1.9%
Div Cover 3.2 3.0
Op Mrgn 26.0% 23.9%
ROCE 87.7%  
Latest F'cast
P/E 17.8 17.1
PEG 1.9 8.8
Pr/Revenue 3.3 3.1
Pr/Book 1.8  
Latest F'cast
Revenue 101.7% 6.4%
PBT 46.4% 11.3%
EPS 9.4% 1.9%
DPS 10.0% 6.8%

Alliance Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 44.90 10.81 3.61p 8.8 n/a -0% 0.82p 2.6%
31-Dec-13 45.28 12.01 3.82p 10.6 1.8 +6% 0.91p 2.2%
31-Dec-14 43.54 10.16 3.36p 10.9 n/a -12% 1.00p 2.7%
31-Dec-15 48.34 15.18 3.52p 12.2 2.4 +5% 1.10p 2.6%
31-Dec-16 97.49 22.22 3.85p 12.3 1.4 +9% 1.21p 2.6%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Alliance Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 103.70 24.73 3.92p 17.5 9.4 +2% 1.29p 1.9%
31-Dec-18 117.05 28.11 4.53p 15.2 1.0 +16% 1.44p 2.1%
31-Dec-19 123.82 31.35 5.05p 13.6 1.2 +12% 1.57p 2.3%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

Alliance Pharma Company Announcements

Total Voting Rights 02-Jan-2018 14:00 RNS
Block Listing Six Monthly Return 02-Jan-2018 07:00 RNS
Completion of acquisition of Vamousse 28-Dec-2017 07:00 RNS

Latest Alliance Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 68.40p
Change Today -0.30p
% Change -0.44 %
52 Week High 69.00
52 Week Low 45.13
Volume 897,863
Shares Issued 474.99m
Market Cap 324.89m
RiskGrade 122

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
84.55% below the market average84.55% below the market average84.55% below the market average84.55% below the market average84.55% below the market average
14.75% below the sector average14.75% below the sector average14.75% below the sector average14.75% below the sector average14.75% below the sector average
Price Trend
78.37% above the market average78.37% above the market average78.37% above the market average78.37% above the market average78.37% above the market average
78.46% above the sector average78.46% above the sector average78.46% above the sector average78.46% above the sector average78.46% above the sector average
Income
38.61% below the market average38.61% below the market average38.61% below the market average38.61% below the market average38.61% below the market average
16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average
Growth
76.61% above the market average76.61% above the market average76.61% above the market average76.61% above the market average76.61% above the market average
76.74% above the sector average76.74% above the sector average76.74% above the sector average76.74% above the sector average76.74% above the sector average

What The Brokers Say

Strong Buy 2
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 3
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Interim Final
Ex-Div 21-Dec-17 15-Jun-17
Paid 11-Jan-18 12-Jul-17
Amount 0.44p 0.81p

Trades for 19-Jan-2018

Time Volume / Share Price
16:51 666 @ 68.23p
16:35 14,392 @ 68.40p
16:29 1,124 @ 69.00p
16:29 48 @ 69.00p
16:29 19 @ 69.00p

Alliance Pharma Key Personnel

CEO John Dawson
Chair Andrew L Smith
Finance Director Andrew Franklin

Top of Page